Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“Today’s HCC MDT wasn’t just a discussion-it was about a patient.
A case that could have gone in multiple directions. Different perspectives, different options. But as each specialty shared their insight, the picture became clearer. What started as uncertainty turned into a well-aligned, patient-centered plan.
This is the true value of knowledge exchange-not just learning from each other, but shaping better decisions for the person behind the diagnosis.
Because at the end, MDT is not about opinions… it’s about giving every patient the best possible chance.
Thanks for your efforts Prof Waleed Abelaty and Prof Tame Elbaz.
Thanks for your efforts all Astrazeneca team.”
Other articles about MDT on OncoDaily.